Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.79% Nasdaq Up1.02%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
147.87 Up 2.45(1.68%) 3:36PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 441,909   400,405   370,091   338,941  
Cost of Revenue51,552  51,358  39,377  35,269  
Gross Profit 390,357   349,047   330,714   303,672  
Operating Expenses
Research Development85,785  88,209  68,563  74,536  
Selling General and Administrative134,819  122,886  123,189  108,826  
Non Recurring31,576  2,573  1,167  3,234  
Others105  104  104  104  
Total Operating Expenses252,285  213,772  193,023  186,700  
Operating Income or Loss 138,072   135,275   137,691   116,972  
Income from Continuing Operations
Total Other Income/Expenses Net712  91  628  940  
Earnings Before Interest And Taxes138,784  135,366  138,319  117,912  
Interest Expense807  1,078  1,056  1,171  
Income Before Tax137,977  134,288  137,263  116,741  
Income Tax Expense156,969  40,503  41,378  34,524  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(18,992)93,785  95,885  82,217  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (18,992) 93,785   95,885   82,217  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (18,992) 93,785   95,885   82,217  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.